Naphthoquinone

Naphthoquinone

SCHEMBL6917183

CCOC(C)OCC.O=C1C=CC(=O)c2ccccc21

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 6/20 0.54
IDO1 P14902 3/20 0.54
MAOA P21397 2/20 0.54
MAOB P27338 2/20 0.54
SNCA P37840 2/20 0.54
AKT1 P31749 1/20 0.54
MAP2K1 Q02750 1/20 0.54
PIN1 Q13526 1/20 0.54
EHMT2 Q96KQ7 1/20 0.54
NSD1 Q96L73 1/20 0.54
EHMT1 Q9H9B1 1/20 0.54
LMNA P02545 3/20 0.46
PTPRC P08575 1/20 0.43
SOAT1 P35610 3/20 0.40
S100A4 P26447 2/20 0.40
CDC25A P30304 3/20 0.39
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
ALDH1A1 P00352 4/20 0.38
MAPT P10636 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthoquinone SCHEMBL459082 0.79 CDC25B (0.64) CDC25BIDO1MAOAMAOBSNCA
Phthalimide SCHEMBL1890816 0.79 GSK3B (0.56) CDC25BIDO1MAOAMAOBLMNA
SCHEMBL5670902 0.77 LMNA (0.63) CDC25BLMNAPTPRCPKML3MBTL1
SCHEMBL722108 0.77 LMNA (0.63) CDC25BLMNAPTPRCPKML3MBTL1
Naphthoquinone SCHEMBL28565535 0.76 IDO1 (0.58) CDC25BIDO1MAOAMAOBSNCA
Naphthoquinone SCHEMBL28553026 0.76 CDC25B (0.52) CDC25BIDO1MAOAMAOBSNCA
SCHEMBL4918898 0.75 LMNA (0.55) LMNAMAPTL3MBTL1KDM4E
Naphthoquinone SCHEMBL8064673 0.74 CDC25B (0.70) CDC25BIDO1MAOAMAOBSNCA
Benzoquinone SCHEMBL18838186 0.74 LMNA (0.60) MAOAMAOBLMNAALDH1A1BLM
Naphthoquinone SCHEMBL28159949 0.74 CDC25B (0.70) CDC25BIDO1MAOAMAOBSNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673937-B2 ANALOGS OF DEOXYPREUSSOMERIN, PALMARUMYCIN CPI AND RELATED NAPHTHOQUINONE SPIROKETALS; INHIBIT THIOREDOXIN-THIOREDOXIN REDUCTASE SYSTEM THE UNIVERSITY OF PITTSBURGH 2004-01-06 US disclosed
US-20020049221-A1 Synthesis and methods of use of new antimitotic agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049221-A1 Synthesis and methods of use of new antimitotic agents TXNRD1, TXNRD3, TXN2 CDC25B 765/4885IDO1 4538/4885MAOA 1277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.